APA Alıntı

Khan, F. H., Pandian, V., Ramraj, S. K., Aravindan, S., Natarajan, M., Azadi, S., . . . Aravindan, N. (2015). RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes. Oncotarget.

Chicago Stili Alıntı

Khan, Faizan H., Vijayabaskar Pandian, Satish Kumar Ramraj, Sheeja Aravindan, Mohan Natarajan, Seifollah Azadi, Terence S. Herman, ve Natarajan Aravindan. "RD3 Loss Dictates High-risk Aggressive Neuroblastoma and Poor Clinical Outcomes." Oncotarget 2015.

MLA Alıntı

Khan, Faizan H., et al. "RD3 Loss Dictates High-risk Aggressive Neuroblastoma and Poor Clinical Outcomes." Oncotarget 2015.